This closely matches the values for total ezrin (Fig. 3B), but not total radixin (Fig. 3A), supporting the conclusion that ezrin expression and activation state correlates with NSC sensitivity in this panel of breast cancer cell lines. The gene discussed is EZR; the disease is breast carcinoma.